Acute bronchitis (2024)

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice

Acute bronchitis (1)

Link to Publisher's site

Does bronchitis really exist?

Hueston et al

About 5% of adults self-report an episode of acute bronchitis each year, and up to 90% of them seek medical advice. Viruses appear to be mainly responsible, causing up to 95% of cases of acute bronchitis in otherwise healthy adults. The viruses are the same as those that cause the common cold.

Isolated bacteria are usually commensals from the oropharynx.

  • Acute bronchitis is the fifth most common reason why adults see their GP; 5% of the adult population seeks medical advice for bronchitis each year.

  • On average, each attack results in 2 to 3 days off work.

  • Viruses cause 85% to 95% of cases of acute bronchitis in healthy adults.

  • The most common viruses are rhinovirus, adenovirus, influenza A and B, and parainfluenza virus; bacteria are usually commensals.

  • Bacteria can cause bronchitis in people with underlying health problems. Mycoplasma pneumoniae, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Bordetella pertussis are most commonly involved.

Clinical course and diagnosis

Acute bronchitis is an acute infection of the tracheosbronchial tree; its hallmark is a productive cough. Some doctors have questioned whether bronchitis is a clear diagnostic entity; maybe it is just a cold on the chest. Coloured sputum cannot be used to predict whether an infection is viral or bacterial.

There are no reliable diagnostic signs or laboratory tests, so the diagnosis of acute bronchitis is essentially a clinical one. The most important condition to rule out is acute pneumonia. This can be difficult, as patients with pneumonia and those with bronchitis can both have added lung sounds and fever (unfortunately, these signs are neither sensitive nor specific for pneumonia). Colds and sinusitis can cause productive cough. Bronchitis patients often show signs of bronchial obstruction, such as wheezing or dyspnea on exertion. However, unlike that in asthma, the inflammation in acute bronchitis is transient and usually completely resolves soon after the infection clears up.

Spirometry in acute bronchitis overlaps with asthma; forced expiratory volume in 1 second and peak flow rate decline in almost 60% of people with acute bronchitis.

  • The common symptom is an acute cough, which is usually productive. The cough lasts for less than 3 weeks in 50% of patients, but for more than 1 month in 25% of patients.

  • The appearance of the sputum cannot be used to distinguish between viral and bacterial bronchitis.

  • There is no reliable diagnostic sign or laboratory test; the diagnosis is a clinical one.

  • There is considerable clinical overlap between acute bronchitis and the other acute respiratory infections, asthma, and pneumonia.

  • Results from the control groups of trials show that 85% of patients will improve without specific treatment.

Treatment

Some of the systematic reviews found no benefit from using antibiotics; others found some modest treatment effects when antibiotics were compared with placebo. The consensus seems to be that antibiotics have a modest benefit for only a minority of patients and are not needed to treat most patients with acute bronchitis.

Amoxicillin, doxycycline, erythromycin, and trimethoprim-sulfamethoxazole seem reasonable first choices. The evidence for bronchodilators is conflicting. A review by Williamson claims that randomized clinical trials support the use of bronchodilators; however, a review by Smucny et al states that there is no consistent benefit.

Nonspecific cough therapy is commonly prescribed to patients either together with or in lieu of antibiotics, but the evidence is weak. The very recent evidence-based guideline by the American College of Chest Physicians suggests that antitussive agents are occasionally useful and can be offered for short-term symptomatic relief of coughing.

Patients should be given a realistic prediction of the duration of their cough, which will typically last for at least 10 to 14 days after the office visit. Doctors might consider calling the cough a chest cold rather than acute bronchitis.

  • Antibiotics confer only minimal benefits on healthy adults with bronchitis:

    • —a reduction in cough duration (number needed to treat = 5) and

    • —a slightly earlier return to work (number needed to treat = 18).

  • Antibiotics can have a modest beneficial effect in certain groups of patients, such as older and debilitated people, but smokers do not gain any additional benefit from them.

  • Antibiotics cause side effects (number needed to harm = 14).

  • Bronchodilators can help to relieve the cough in people who show evidence of bronchospasm.

  • Cough suppressants are of no value for either adults or children.

Footnotes

Adapted from: Worrall G. There’s a lot of it about: acute respiratory infection in primary care. Abingdon, Engl: Radcliffe Publishing Ltd; 2006.

Competing interests

None declared

References

Alberta Clinical Guidelines Program. Towards Optimal Practice: guidelines for the management and treatment of acute bronchitis. Edmonton, AB: Alberta Clinical Guidelines Program; 2005. [Accessed 2007 Dec 19]. Available from: www.topalbertadoctors.org/TOP/CPG/Bronchitis. [Google Scholar]

Fahey T, Stocks N, Thomas R. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ. 1998;316(7135):906–10. [PMC free article] [PubMed] [Google Scholar]

Hueston WJ, Mainous AG, Dacus EN, Hopper JE. Does acute bronchitis really exist? J Fam Practice. 2000;47:401–7. [PubMed] [Google Scholar]

Irwin RS, Baumann MH, Bosler DC, Boulet LP, Braman SS, Brightling CE, et al. Diagnosis and management of cough: executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):1S–23S. [PMC free article] [PubMed] [Google Scholar]

Smucny J, Becker L, Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev. 2006;(4):CD001726. [PubMed] [Google Scholar]

Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2004;(4):CD000245. [PubMed] [Google Scholar]

Williamson HA., Jr Pulmonary function tests in acute bronchitis: evidence for reversible airways obstruction. J Fam Practice. 1987;25:251–6. [PubMed] [Google Scholar]

Worrall G. Acute bronchitis. In: Worrall G, editor. There’s a lot of it about: acute respiratory infection in primary care. Abingdon, Engl: Radcliffe Publishing Ltd; 2006. pp. 58–66. [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

Acute bronchitis (2024)
Top Articles
Latest Posts
Article information

Author: Moshe Kshlerin

Last Updated:

Views: 6053

Rating: 4.7 / 5 (77 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Moshe Kshlerin

Birthday: 1994-01-25

Address: Suite 609 315 Lupita Unions, Ronnieburgh, MI 62697

Phone: +2424755286529

Job: District Education Designer

Hobby: Yoga, Gunsmithing, Singing, 3D printing, Nordic skating, Soapmaking, Juggling

Introduction: My name is Moshe Kshlerin, I am a gleaming, attractive, outstanding, pleasant, delightful, outstanding, famous person who loves writing and wants to share my knowledge and understanding with you.